Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 26 years of covering Asia Pacific equities, the past 20 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

Insignia Financial (IFL AU): Bain Rejection Follows Tanarra's Lead

Insignia Financial (IFL AU): CC Capital Wades In With A $4.30/Share NBIO

Insignia Financial (IFL AU): Bain Calls CC Capital's $4.30/Share NBIO

Quiddity Advisors

Event-Driven

<ul>
<li>
<a href="https://www.smartkarma.com/entities/ioof-holdings-ltd" target="_blank" data-smartkarma-citation="entities:12349:1" rel="noopener"><strong>Insignia Financial (IFL AU)</strong></a>, a wealth manager and previously known as IOOF, has announced a <strong><a href="https://announcements.asx.com.au/asxpdf/20241213/pdf/06clql94x0mq9g.pdf" target="_blank" rel="noopener">A$4.00/share non-binding and indicative proposal</a></strong> from PE outfit Bain Capital.</li>
<li>The Offer, should it proceed, will be by way of a Scheme.  Apart from IFL's shareholder approval, a firm bid requires FIRB signing off. </li>
<li>IFL's board is weighing up the Offer's pros and cons. This probably requires a small bump.</li>
</ul>



Insignia Financial (IFL AU), a wealth manager and previously known as IOOF, has announced a A$4.00/share non-binding and indicative proposal from PE outfit Bain Capital.
The Offer, should it proceed, will be by way of a Scheme.  Apart from IFL's shareholder approval, a firm bid requires FIRB signing off. 
IFL's board is weighing up the Offer's pros and cons. This probably requires a small bump.


Washington H. Soul Pattinson and Co. Ltd (SOL AU)

Insignia Financial (IFL AU): Bain's A$4.00/Share NBIO. Needs More Gruel